The present invention relates to the treatment of a hypersensitivity immune response, such as allergic rhinitis or asthma, via bystander suppression by use of an antigen unrelated to the allergen triggering the hypersensitivity immune responsein an individual to be treated, wherein the antigen is obtainable from the source material comprising the "triggering" allergen.